Influence of hydrogenated fat and butter on CVD risk factors: Remnant-like particles, glucose and insulin, blood pressure and C-reactive protein

Atherosclerosis

Volumn 171, Issue 1, 2003, Pages 97-107

  Lichtenstein, Alice H ^a   Erkkilä, Arja T ^a,b   Lamarche, Benoît ^c   Schwab, Ursula S ^b   Jalbert, Susan M ^a   Ausman, Lynne M ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Blood pressure; C reactive protein; Glucose; HDL cholesterol; Hydrogenated fat; Insulin; LDL cholesterol; Remnant like particles; Saturated fat; Trans fatty acids

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL ESTER; FAT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MARGARINE; PHOSPHOLIPID; SOYBEAN OIL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BUTTER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0345283050     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.07.005     Document Type: Article

References (65)

1. Judd J.T., Clevidence B.A., Muesing R.A., Wittes J., Sunkin M.E., Podczasy J.J. Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am. J. Clin. Nutr. 59(4):1994;861-868.
2. Lichtenstein A.H., Ausman L.A., Jalbert S.M., Schaefer E.J. Comparison of different forms of hydrogenated fats on serum lipid levels in moderately hypercholesterolemic female and male subjects. New Engl. J. Med. 340:1999;1933-1940.
3. Mensink R.P., Katan M.B. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. New England J. Med. 323(7):1990;439-445.
4. Oomen C.M., Ocke M.C., Feskens E.J., van Erp-Baart M.A., Kok F.J., Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 357(9258):2001;746-751.
5. Kromhout D., Menotti A., Bloemberg B., Aravanis C., Blackburn H., Buzina R.et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev. Med. 24(3):1995;308-315.
6. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Rosner B.A. et al. Dietary fat intake and the risk of coronary heart disease in women. New England J. Med. 337(21):1997;1491-1499.
7. Salmeron J., Hu F.B., Manson J.E., Stampfer M.J., Colditz G.A., Rimm E.B.et al. Dietary fat intake and risk of type 2 diabetes in women. Am. J. Clin. Nutr. 73(6):2001;1019-1026.
8. Lovejoy J.C., Champagne C.M., Smith S.R., DeLany J.P., Bray G.A., Lefevre M.et al. Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. Metab: Clin. Exp. 50(1):2001;86-92.
9. Lovejoy J.C., Smith S.R., Champagne C.M., Most M.M., Lefevre M., DeLany J.P.et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diab. Care. 25(8):2002;1283-1288.
10. Louheranta A.M., Turpeinen A.K., Vidgren H.M., Schwab U.S., Uusitupa M.I. A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metab.: Clin. Exp. 48(7):1999;870-875.
11. Maron D.J., Fair J.M., Haskell W.L. Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford Coronary Risk Intervention Project Investigators and Staff. Circulation. 84(5):1991;2020-2027.
12. Uusitupa M., Schwab U., Makimattila S., Karhapaa P., Sarkkinen E., Maliranta H.et al. Effects of two high-fat diets with different fatty acid compositions on glucose and lipid metabolism in healthy young women. Am. J. Clin. Nutr. 59(6):1994;1310-1316.
13. Storlien L.H., Baur L.A., Kriketos A.D., Pan D.A., Cooney G.J., Jenkins A.B.et al. Dietary fats and insulin action. Diabetologia. 39(6):1996;621-631.
14. Pirro M., Bergeron J., Dagenais G.R., Bernard P.M., Cantin B., Despres J.P.et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch. Intern. Med. 161(20):2001;2474-2480.
15. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England J. Med. 347(20):2002;1557-1565.
16. Madsen T., Skou H.A., Hansen V.E., Fog L., Christensen J.H., Toft E.et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am. J. Cardiol. 88(10):2001;1139-1142.
17. Mezzano D., Leighton F., Martinez C., Marshall G., Cuevas A., Castillo O.et al. Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. Eur. J. Clin. Nutr. 55(6):2001;444-451.
18. Nordstrom D.C., Honkanen V.E., Nasu Y., Antila E., Friman C., Konttinen Y.T. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed. Rheumatol. Interv. 14(6):1995;231-234.
19. Cambien F., Jacqueson A., Richard J.L., Warnet J.M., Ducimetiere P., Claude J.R. Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study. Am. J. Epidemiol. 124(4):1986;624-632.
20. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3(2):1996;213-219.
21. Fukushima H., Kugiyama K., Sugiyama S., Honda O., Koide S., Nakamura S. et al. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease. Am. J. Cardiol. 88(12):2001;1370-1373.
22. McNamara J.R., Shah P.K., Nakajima K., Cupples L.A., Wilson P.W., Ordovas J.M.et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis. 154(1):2001;229-236.
23. Lichtenstein A.H., Jauhiainen M., McGladdery S., Ausman L.M., Jalbert S.M., Vilella-Bach M.et al. Impact of hydrogenated fat on high density lipoprotein subfractions and metabolism. J. Lipid Res. 42(4):2001;597-604.
24. Grundy S.M. Approach to lipoprotein management in 2001 National Cholesterol Guidelines. Am. J. Cardiol. 90(8A):2002;11i-21i.
25. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
26. McNamara J.R., Schaefer E.J. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin. Chim. Acta. 166(1):1987;1-8.
27. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28(6):1982;1379-1388.
28. Contois J.H., McNamara J.R., Lammi-Keefe C.J., Wilson P.W., Massov T., Schaefer E.J. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin. Chem. 42(4):1996;515-523.
29. Contois J., McNamara J.R., Lammi-Keefe C., Wilson P.W., Massov T., Schaefer E.J. Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin. Chem. 42(4):1996;507-514.
30. Jenner J.L., Ordovas J.M., Lamon-Fava S., Schaefer M.M., Wilson P.W., Castelli W.P.et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation. 87(4):1993;1135-1141.
31. Vidgren H.M., Louheranta A.M., Agren J.J., Schwab U.S., Uusitupa M.I. Divergent incorporation of dietary trans fatty acids in different serum lipid fractions. Lipids. 33(10):1998;955-962.
32. McNamara J.R., Shah P.K., Nakajima K., Cupples L.A., Wilson P.W., Ordovas J.M.et al. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin. Chem. 44(6 Pt 1):1998;1224-1232.
33. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7):1985;412-419.
34. Wallace T.M., Matthews D.R. The assessment of insulin resistance in man. Diab. Med. 19:2002;527-534.
35. Perez-Jimenez F., Lopez-Miranda J., Mata P. Protective effect of dietary monounsaturated fat on arteriosclerosis: beyond cholesterol. Atherosclerosis. 163(2):2002;385-398.
36. Liu S., Manson J.E., Buring J.E., Stampfer M.J., Willett W.C., Ridker P.M. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am. J. Clin. Nutr. 75(3):2002;492-498.
37. Mensink R.P., Hornstra G. The proportion of trans monounsaturated fatty acids in serum triacylglycerols or platelet phospholipids as an objective indicator of their short-term intake in healthy men. Br. J. Nutr. 73(4):1995;605-612.
38. Zock P.L., Mensink R.P. Dietary trans-fatty acids and serum lipoproteins in humans. Curr. Opin. Lipidol. 7(1):1996;34-37.
39. Seppanen-Laakso T., Laakso I., Backlund P., Vanhanen H., Viikari J. Elaidic and trans-vaccenic acids in plasma phospholipids as indicators of dietary intake of 18:1 trans-fatty acids. J. Chromatogr. B: Biomed. Appl. 687(2):1996;371-378.
40. Raatz S.K., Bibus D., Thomas W., Kris-Etherton P. Total fat intake modifies plasma fatty acid composition in humans. J. Nutr. 131(2):2001;231-234.
41. Sebedio J.L., Vermunt S.H., Chardigny J.M., Beaufrere B., Mensink R.P., Armstrong R.A.et al. The effect of dietary trans alpha-linolenic acid on plasma lipids and platelet fatty acid composition: the TransLinE study. Eur. J. Clin. Nutr. 54(2):2000;104-113.
42. Mansour M.P., Li D., Sinclair A.J. The occurrence of trans-18:1 isomers in plasma lipids classes in humans. Eur. J. Clin. Nutr. 55(1):2001;59-64.
43. Aro A., Jauhiainen M., Partanen R., Salminen I., Mutanen M. Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am. J. Clin. Nutr. 65(5):1997;1419-1426.
44. Forrester J.S. Triglycerides: risk factor or fellow traveler? Curr. Opin. Cardiol. 16(4):2001;261-264.
45. Cohn J.S., McNamara J.R., Schaefer E.J. Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states. Clin. Chem. 34(12):1988;2456-2459.
46. Zilversmit D.B. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin. Chem. 41(1):1995;153-158.
47. Masuoka H., Kamei S., Ozaki M., Kawasaki A., Shintani U., Ito M.et al. Predictive value of remnant-like particle cholesterol as an indicator of coronary artery stenosis in patients with normal serum triglyceride levels. Intern. Med. 39(7):2000;540-546.
48. Karpe F., Boquist S., Tang R., Bond G.M., de Faire U., Hamsten A. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J. Lipid Res. 42(1):2001;17-21.
49. Nakamura N., Hamazaki T., Kobayashi M., Ohta M., Okuda K. Effects of eicosapentaenoic acids on remnant-like particles. In Vivo. 12(3):1998;311-314.
50. Higashi K., Shige H., Ito T., Nakajima K., Ishikawa T., Nakamura H.et al. Effect of a low-fat diet enriched with oleic acid on postprandial lipemia in patients with type 2 diabetes mellitus. Lipids. 36(1):2001;1-6.
51. Mensink R.P., de Louw M.H., Katan M.B. Effects of dietary trans fatty acids on blood pressure in normotensive subjects. Eur. J. Clin. Nutr. 45(8):1991;375-382.
52. von Houwelingen R., Nordoy A., van der Beek E., Houtsmuller U., de Metz M., Hornstra G. Effect of a moderate fish intake on blood pressure, bleeding time, hematology, and clinical chemistry in healthy males. Am. J. Clin. Nutr. 46(3):1987;424-436.
53. Mensink R.P., Janssen M.C., Katan M.B. Effect on blood pressure of two diets differing in total fat but not in saturated and polyunsaturated fatty acids in healthy volunteers. Am. J. Clin. Nutr. 47(6):1988;976-980.
54. Mori T.A., Bao D.Q., Burke V., Puddey I.B., Beilin L.J. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension. 34(2):1999;253-260.
55. Ferrara L.A., Raimondi A.S., d'Episcopo L., Guida L., Dello Russo A., Marotta T. Olive oil and reduced need for antihypertensive medications. Arch. Intern. Med. 160(6):2000;837-842.
56. Grimsgaard S., Bonaa K.H., Jacobsen B.K., Bjerve K.S. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension. 34(3):1999;478-483.
57. Tchernof A., Nolan A., Sites C.K., Ades P.A., Poehlman E.T. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 105(5):2002;564-569.
58. Heilbronn L.K., Noakes M., Clifton P.M. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler., Thromb. Vasc. Biol. 21(6):2001;968-970.
59. Festa A., D'Agostino R. Jr., Tracy R.P., Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 51(4):2002;1131-1137.
60. Mayer-Davis E.J., Monaco J.H., Hoen H.M., Carmichael S., Vitolins M.Z., Rewers M.J.et al. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS). Am. J. Clin. Nutr. 65(1):1997;79-87.
61. Lovejoy J.C., Windhauser M.M., Rood J.C., de la Bretonne J.A. Effect of a controlled high-fat versus low-fat diet on insulin sensitivity and leptin levels in African-American and Caucasian women. Metab.: Clin. Exp. 47(12):1998;1520-1524.
62. Alstrup K.K., Gregersen S., Jensen H.M., Thomsen J.L., Hermansen K. Differential effects of cis and trans fatty acids on insulin release from isolated mouse islets. Metab.: Clin. Exp. 48(1):1999;22-29.
63. Opara E.C., Go V.L. Regulation of polyunsaturated fatty acid-stimulated insulin release by GIP in isolated perifused islets. Pancreas. 9(3):1994;291-296.
64. Christiansen E., Schnider S., Palmvig B., Tauber-Lassen E., Pedersen O. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diab. Care. 20(5):1997;881-887.
65. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B.et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diab. Care. 23(1):2000;57-63.